Detalhe da pesquisa
1.
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Clin Infect Dis
; 68(7): 1213-1222, 2019 03 19.
Artigo
Inglês
| MEDLINE | ID: mdl-30759183
2.
Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence.
Int J Infect Dis
; 144: 107047, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38609035
3.
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines.
EClinicalMedicine
; 37: 100976, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34386749
4.
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Lancet Infect Dis
; 18(1): 58-67, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29066131
5.
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.
Lancet Infect Dis
; 18(11): 1260-1268, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30266329